Purple Biotech Ltd (TLV: PPBT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
6.60
+0.20 (3.13%)
Jan 20, 2025, 5:24 PM IDT

Purple Biotech Market Cap

Purple Biotech has a market cap or net worth of 34.65 million as of January 22, 2025. Its market cap has decreased by -56.28% in one year.

Market Cap
34.65M
Enterprise Value
12.26M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.60

Market Cap Chart

Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 34.65M, an increase of 93.84%. That is a compound annual growth rate of 5.91%.

History

DateMarket Cap% Change
Jan 21, 202534.65M-14.10%
Dec 31, 202440.34M-48.30%
Dec 31, 202378.02M-17.30%
Dec 29, 202294.35M-55.64%
Dec 30, 2021212.71M-1.36%
Dec 31, 2020215.65M332.51%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 31, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Teva Pharmaceutical Industries 88.56B
Danel (Adir Yeoshua) 2.55B
Kamada 1.47B
Bait Bakfar 1.05B
Novolog (Pharm-Up 1966) 965.26M
Ilex Medical 870.07M
BrainsWay 694.21M
SofWave Medical 608.67M
Market Cap Rankings